Photo from Shearwood McClelland III/X
Oct 11, 2024, 15:13
Shearwood McClelland III: Grateful to Radiation Oncology Institute for recognizing our Navigator-Assisted Hypofractionation program
Shearwood McClelland III shared a post on X:
”Once again grateful to the Radiation Oncology Institute for recognizing our Navigator-Assisted Hypofractionation (NAVAH) program expansion to help Hispanic breast cancer patients with 1 of the 4 innovation grants awarded nationally this year!”
Source: Shearwood McClelland III/X
Shearwood McClelland III, M.D., is the Director of Spine Oncology at University Hospitals’ Department of Radiation Oncology. His research focuses on improving radiation therapy access for underrepresented minorities using hypofractionation and addressing healthcare disparities. He also led the first U.S. analysis of spine stereotactic body radiation therapy (SBRT) usage.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 3, 2025, 05:10
Aug 3, 2025, 04:58
Aug 3, 2025, 01:15